Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Kiromic Biopharma, Inc. (KRBP)
|
Add to portfolio |
|
|
Price: |
$1.73
| | Metrics |
OS: |
1.18
|
M
| |
|
|
Market cap: |
$2.03
|
M
| |
|
|
Net debt:
|
$5.56
|
M
| |
|
|
EV:
|
$7.59
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
Revenues | 0.0 | 0.0 | 0.0 | 1.4 |
Revenue growth | | | -100.0% | |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 3.2 |
Gross profit | 0.0 | 0.0 | 0.0 | -1.8 |
Gross margin | | | | -123.4% |
Research and development | 11.4 | 5.1 | 1.2 | |
General and administrative | 13.9 | 14.1 | 2.5 | 1.8 |
EBIT | -25.3 | -19.2 | -3.7 | -3.2 |
EBIT margin | | | | -223.4% |
Pre-tax income | -25.6 | -19.2 | -3.7 | -3.8 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -25.6 | -19.2 | -3.7 | -3.8 |
Net margin | | | | -267.8% |
|
Diluted EPS | ($2.24) | ($4.26) | ($1.30) | ($1.33) |
Shares outstanding (diluted) | 11.4 | 4.5 | 2.9 | 2.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|